Effect of LAF237 on Glucagon Secretion in Patients With Type 2 Diabetes and in Healthy Subjects

Clinical trial NCT00651105 · COMPLETED

Trial details

NCT number: NCT00651105
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type-2 Diabetes Healthy

Start date: 2008-02-01
Primary completion: 2009-05-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.